## Abstract ## BACKGROUND The authors conducted a series of four Phase IโII trials of highโdose and intermediateโdose docetaxel, cisplatin, and 5โfluorouracil (TPF)โbased induction chemotherapy for patients with advanced squamous cell carcinoma of the head and neck (SCCHN). The chemotherapy regime
Optimizing docetaxel chemotherapy in patients with cancer of the gastric and gastroesophageal junction : Evolution of the docetaxel, cisplatin, and 5-fluorouracil regimen
โ Scribed by Jaffer A. Ajani
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 191 KB
- Volume
- 113
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract We have recently demonstrated in a Phase I/II study that combination chemotherapy with docetaxel (TXT) and Sโ1 is active against metastatic gastric carcinomas. To elucidate the mechanisms underlying the synergistic effects of these drugs, both the growth inhibitory effects and the expre
## Abstract ## PURPOSE The authors conducted a singleโinstitution Phase I clinical trial to determine the maximum tolerated doses and to define the toxic effects of oral eniluracil and oral 5โfluorouracil (5โFU) combined with docetaxel in patients with metastatic breast carcinoma. ## PATIENTS AND
## Abstract ## BACKGROUND Patients with localized esophageal carcinoma often develop locoregional and distant disease recurrence. The current study investigated the outcome of a new chemotherapy combination as induction therapy before chemoradiotherapy. ## METHODS Fortyโthree patients with resec
## Abstract ## Background. Intraoperative manipulation of the tumor during cancer surgery has long been recognized as a source of metastasis and contamination of the surgical wound during tumor removal. We explored the use of intraoperative chemotherapy to minimize the risk of tumor cell implantat